Patents by Inventor Maria Carla Baggio

Maria Carla Baggio has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • A PROCESS FOR THE PRODUCTION OF AMCIPATRICIN DIASCORBATE AND THE USE OF THE SAME FOR THE TREATMENT OF INVASIVE FUNGAL INFECTIONS RESISTANT TO TRADITIONAL ANTIFUNGAL AGENTS
    Publication number: 20240317791
    Abstract: The invention relates to a process for the production of amcipatricin diascorbate and the use of the same for an improved treatment of invasive fungal infections having proof/prevalence of resistance to traditional antifungal agents.
    Type: Application
    Filed: July 8, 2022
    Publication date: September 26, 2024
    Applicant: BIOSEUTICA B.V.
    Inventors: Valerio Maria Ferrari, Maria Carla Baggio, Mario Vigilante, Alessandro Calizzi, Tiberio Bruzzese, Paride Grisenti
  • OVOTRANSFERRINS FOR USE IN THE TREATMENT OF IRON DEFICIENCY ANAEMIA
    Publication number: 20240148837
    Abstract: Ovotransferrins with a degree of iron saturation from 0 to 15% are useful in the treatment of iron deficiency and iron deficiency anaemia, increasing the cell viability on gastric and intestinal cell models with respect to the holo-OvT 100%, when tested at the same concentrations, showing also a surprisingly better time dependent absorption of iron ions and a physiological trend allowing a single oral administration in 24 hours.
    Type: Application
    Filed: February 21, 2022
    Publication date: May 9, 2024
    Applicant: BIOSEUTICA B.V.
    Inventors: Valerio Maria Ferrari, Maria Carla Baggio, Paride Grisenti
  • A NEW PROCESS OF PURIFICATION OF PROTEINS FROM HEN EGG WHITE AND THE USE OF THE SAME AS ANTIVIRAL AGENT AGAINST SARS-COV-2
    Publication number: 20230174575
    Abstract: The present invention describes a novel process for the production of lysozyme HCl from hen egg white (HEW) with high chemical purity, and the use of said antiviral agent against SARS-CoV-2, optionally combined with other antivirals and/or immunosuppressants and ovotransferrin.
    Type: Application
    Filed: May 11, 2021
    Publication date: June 8, 2023
    Applicant: BIOSEUTICA B.V.
    Inventors: Valerio Maria Ferrari, Maria Carla Baggio, Paride Grisenti